Related Experiment Video
Updated: Sep 30, 2025

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Vaccination against Atherosclerosis: Is It Real?
Anastasia V Poznyak1, Evgeny E Bezsonov2,3,4, Tatyana V Popkova5
1Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia.
Insights
Atherosclerosis, a vascular disease linked to diet and lifestyle, may be preventable with vaccines targeting the immune response. Research explores immune involvement in atherogenesis for potential cardiovascular risk reduction.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Pathology
Background:
- Atherosclerosis is a long-recognized vascular disease often linked to lifestyle factors and prevalent in developed nations.
- While treatments exist, prevention strategies like vaccination are crucial for reducing mortality.
- Understanding the immune system's role is key to developing novel preventive measures.
Purpose of the Study:
- To review the involvement of immune responses in the development of atherosclerotic lesions.
- To discuss modern concepts of atherogenesis and immune inflammation in atherosclerosis.
- To identify potential vaccine targets for preventing atherosclerosis and reducing cardiovascular risk.
Main Methods:
- Literature review of experimental and clinical data.
- Analysis of modern concepts in atherogenesis and immune inflammation.
- Evaluation of potential immune targets for vaccine development.
Main Results:
- The immune response plays a significant role in the pathogenesis of atherosclerotic lesions.
- Immune inflammation is a key component of atherosclerosis development.
- Several potential targets for immune-based therapies and vaccines have been identified.
Conclusions:
- Vaccination strategies targeting the immune system offer a promising avenue for atherosclerosis prevention.
- Immune therapies hold potential for reducing cardiovascular risk associated with atherosclerosis.
- Further research into immune mechanisms is essential for developing effective vaccines and treatments.
Abstract:
Atherosclerosis has been known in medicine for several centuries. As early as 1755, the Swedish anatomist Albrecht von Haller used the term "atheroma" to describe vascular lesions. Atherosclerosis may originate from an unbalanced diet or bad habits, and is mainly found in developed countries. Clinical trials have been conducted to establish the causes of atherosclerosis, and also to develop treatments for this disease. However, prevention of the disease has always been better than treatment, so vaccination may be the key to saving thousands of lives. The creation of a vaccine may be directly related to the study of autoimmune processes occurring in the body, immunity. This review considers the issues related to the involvement of the immune response in the development of atherosclerotic lesions. Modern concepts of atherogenesis, immune inflammation in atherosclerosis, and potential vaccine targets are also discussed. There is a particular focus on experimental and clinical data supporting the development of immune therapies to reduce cardiovascular risk.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Vaccinations

